Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

65429 Press Releases
DateTitleCompany
03 Apr 12 Patient Services, Inc. Transitions Patient Assistance Items Program to Hemophilia Federation of America PATIENT SERVICES INC.,
Published by
PR Newswire
03 Apr 12 Frost & Sullivan: Economic Downturn Compelled Pharmacists in the United States to Assume Additional Responsibilities Frost & Sullivan,
Published by
PR Newswire
03 Apr 12 Neupro® approved by U.S. FDA for Parkinson’s Disease and Restless Legs Syndrome UCB
03 Apr 12 Amgen and AstraZeneca Announce Collaboration to Jointly Develop and Commercialize Clinical-Stage Inflammation Portfolio Amgen
03 Apr 12 Charlie Wilson Teams Up With Janssen Biotech to Launch Making Awareness a Priority (M.A.P.) Janssen Biotech
03 Apr 12 NICE FAILS TO GRANT ACCESS TO INNOVATIVE TREATMENT FOR WOMEN WITH ADVANCED BREAST CANCER, DESPITE EVIDENCE THAT IT COULD EXTEND THEIR LIVES Eisai,
Published by
Eisai Europe Ltd
03 Apr 12 Cerus Announces New Supply Agreement with Largest Blood Service in Saudi Arabia Cerus Corporation,
Published by
Business Wire
03 Apr 12 Octapharma Group Releases 2011 Annual Report Octapharma,
Published by
Business Wire
03 Apr 12 Biomet Announces Offer to Acquire DePuy Trauma Business Biomet Inc.,
Published by
Business Wire
03 Apr 12 FYI from Human Genome Sciences: GlaxoSmithKline Announces Further Data from Phase 3 Trials of Albiglutide Human Genome Sciences Inc.,
Published by
Business Wire
03 Apr 12 Navidea Biopharmaceuticals Presents Favorable Comparison of Lymphoseek® to Sulfur Colloid at Sentinel Node Oncology Foundation and Sentinel Lymph Node Working Group Navidea Biopharmaceuticals Inc.,
Published by
Business Wire
03 Apr 12 Abiomed Announces First Patient Supported with Impella cVAD Abiomed Inc.,
Published by
Business Wire
03 Apr 12 Liquidia CEO to Participate in Biotech Panel to Explore “How to Create 54 Liquidias” Liquidia Technologies,
Published by
Business Wire
03 Apr 12 Acceleron’s ACE-041 Combined with a VEGF Inhibitor Shows Potent Activity in Preclinical Model of VEGF-Resistant Renal Cell Carcinoma Acceleron Pharma Inc.,
Published by
Business Wire
03 Apr 12 Verastem Announces Addition to Russell 2000 Index Verastem Inc.,
Published by
Business Wire
03 Apr 12 Biovest Announces International Members of its Cancer Vaccine Scientific Advisory Board Biovest International Inc.,
Published by
Business Wire
03 Apr 12 OvaScience Appoints Jeffrey D. Capello to Board of Directors OvaScience,
Published by
Business Wire
03 Apr 12 LATITUDE Pharmaceuticals, Inc. Develops a Stable Liquid Glucagon Formulation LATITUDE Pharmaceuticals Inc.,
Published by
Business Wire
03 Apr 12 SANUWAVE’s dermaPACE Shown to Improve Skin Flap Survival SANUWAVE Health Inc.,
Published by
Business Wire
03 Apr 12 Docetaxel Dominates First-Line Metastatic Castrate-Resistant Prostate Cancer Treatment, But Total Patient Share of Zytiga and Jevtana Reach Nearly 50 Percent in the Second and Third-Line Settings According to Surveyed Physicians BioTrends Research Group LLC,
Published by
Business Wire
03 Apr 12 Fenwal Introduces New Aurora™ System for Plasma Collection Fenwal Inc.,
Published by
Business Wire
03 Apr 12 Roche disappointed by Illumina, Inc.’s Board of Directors’ rejection Roche,
Published by
Business Wire
03 Apr 12 The 20th Colloque Médecine et Recherche of the Fondation Ipsen in the Neurosciences Series: “Programmed Cells: from Basic Neuroscience to Therapy” Fondation Ipsen,
Published by
Business Wire
03 Apr 12 Intertek Launches cGMP Cell Based Assays for Biologic Therapeutics in Europe Intertek,
Published by
Business Wire
03 Apr 12 Eisai Diagnostics Subsidiary EIDIA Enters Into Sales Agreements with Medical Equipment Manufacturers for PROTOCO2L Carbon Dioxide Insufflation System for CT Colonography Eisai
03 Apr 12 Meda Expands Presence in Asia MEDA,
Published by
Business Wire
03 Apr 12 ACOS and Avedro Announce Initiation of a Phase 3 Study On Accelerated Corneal Cross-Linking Avedro Inc.,
Published by
Business Wire
03 Apr 12 Neupro® Approved by U.S. FDA for Parkinson’s Disease and Restless Legs Syndrome UCB,
Published by
Business Wire
03 Apr 12 Fibrocell Science, Inc. Reschedules Fourth Quarter 2011 Business Update Investor Conference Call for Tuesday, April 3, at 8:00 AM Eastern Time Fibrocell Science Inc.,
Published by
Business Wire
03 Apr 12 PerkinElmer Launches HER2Sense™ Discovery Research Imaging Agent to Enable Personalized Medicine Approaches for Breast Cancer Research PerkinElmer Inc.,
Published by
Business Wire
Advertising